A few immunosuppressants don’t build COVID-19 risk: Scientists Kumar Jeetendra | September 15, 2020 Therapeutics which suppress the immune system in people who have inflammatory diseases like psoriasis and rheumatoid arthritis”are not associated with a significantly greater risk” for contracting COVID-19, according to a study which says these patients should continue taking their medicine as prescribed. Dermatology researchers in the Henry Ford Health System in the US, which treats …
Aurobindo Pharma ties up with BIRAC to create COVID-19 antibody Kumar Jeetendra | September 15, 2020 Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine. BIRAC has facilitated the establishment of’the r-VSV vaccine’ manufacturing platform for the first time in India by encouraging Aurobindo Pharma’s COVID-19 vaccine development, the company said in a …
2D FFF System Opens Door to New Separations Kumar Jeetendra | September 15, 2020 Postnova Analytics powerful EAF4 technology combines the principle of Electrical and Asymmetrical Flow Field-Flow Fractionation in just one system. Electrical and Cross Flow Fields can now be applied in one Field-Flow Fractionation (FFF) channel opening up completely new routes for separations which are based on particle size / molar mass and also on particle / …
US intends to convey COVID-19 immunization following approval Kumar Jeetendra | September 16, 2020 The US government plans to start distributing a COVID-19 vaccine within one day of any regulatory authorization, an official from the research said on September 16. Government officials also said the US Centers for Disease Control and Prevention will decide how initial, limited vaccine doses will be allocated and distributed.
Dr Reddy’s accomplices with RDIF to convey 100 million doses of Sputnik V antibody in India Kumar Jeetendra | September 16, 2020 Hyderabad, Sep 16 (PTI) The Russian Direct Investment Fund (RDIF), Russias autonomous wealth finance, and Dr Reddys Laboratories Ltd. have agreed to collaborate on clinical trials and supply of Sputnik V vaccine in India. Upon regulatory approval in India, RDIF shall supply to Dr. Reddys 100 million doses of the vaccine, Dr Reddys stated in …
BioChromato’s RAPID Slit Seals offer significant advantages over customary silicone mats Kumar Jeetendra | September 17, 2020 BioChromato Inc. reports that the pharmacokinetics department in a leading Japanese pharmaceutical company has found that RAPID Slit Seals provide significant benefits when compared with conventional silicone mats for maintaining the integrity of microplate samples. In their drive to identify new drug entities the pharmacokinetics division use a mass spectrometer served by an autosampler managing …
Dr Reddy’s’ settles case with Bristol Myers Squibb unit over nonexclusive malignant growth drug Kumar Jeetendra | September 17, 2020 The Hyderabad-based firm has settled litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, Dr Reddy”s Laboratories said in a statement. In settlement of all outstanding claims in the litigation, Celgene has agreed to provide the company with a permit to sell volume-limited amounts of generic lenalidomide capsules in america starting on a confidential …
Aurobindo Pharma ties up with BIRAC to create COVID-19 immunization Kumar Jeetendra | September 17, 2020 Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine. Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. “Aurobindo is in the process of preparing a state-of-art manufacturing facility …
Effect of Discreet Monsoon on Dengue Epidemiology Kumar Jeetendra | September 17, 2020 The arrival Mosquitoes and Dengue with the seasonal rains are pivotal in understanding the pathogenesis of the virus in tropical medicine. Dengue has been a resonant feature in the Indian subcontinent making epidemic outbreaks in the last 4 decades, but it was in the last decade that the diagnosis of the virus took the impetus …
Telstar strengthens a Consultancy service to help pharma laboratories to comply with the new guidelines of EU GMP Annex I Kumar Jeetendra | September 17, 2020 Terrassa (Barcelona) 2020, September 17th. Telstar has reinforced a GMP Pharma Consultancy Service specialized in assessment, diagnostic and implementation of comprehensive solutions for sterile processes and critical installations to operate in accordance with the last version of the EU GMP Annex 1 designed to comply with the maximum level of assurance in sterile production. this …
Understanding latex allergies for enhanced healthcare management Kumar Jeetendra | September 18, 2020 The world is running high on healthcare products, and pervasive use of sanitizers, masks, gloves, and other compound based routine products are probing another challenge altogether. Severe skin allergies are putting a section of the population at high risk causing acute skin irritation, and one such compound is Latex Understanding NRL Allergy Latex-referred as natural …
10th anniversary of Thailand lab international goes hybrid this October “TOGETHER, LET’S COMBAT COVID-19!” Kumar Jeetendra | September 18, 2020 BANGKOK, THAILAND – September 18, 2020 – VNU Asia Pacific, the organizer of Thailand LAB INTERNATIONAL, together with the Science and Technology Trade Association (STTA) and the Thailand Center of Excellence for Life Sciences (TCELS), are thrilled to celebrate its 10th Anniversary from October 28-30, 2020 at BITEC. Thailand LAB INTERNATIONAL strives to be one …
